Loading...

Medexus Pharmaceuticals Inc.

MEDXF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$2.87
$-0.06(-2.05%)
U.S. Market opens in 7h 43m

Medexus Pharmaceuticals Inc. (MEDXF) Stock Overview

Explore Medexus Pharmaceuticals Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap92.7M
P/E Ratio-342.17
EPS (TTM)$-0.02
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$2.40
3 Months$1.80
1 Year Target$2.38

MEDXF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Medexus Pharmaceuticals Inc. (MEDXF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.45, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.38.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -342.17 and a market capitalization of 92.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.05%
5-Day Change
N/A
1-Month Change
12.11%
3-Month Change
39.32%
6-Month Change
51.05%
Year-to-Date (YTD) Change
36.02%
1-Year Change
43.50%
3-Year Change
175.96%
5-Year Change
-52.95%
All-Time (Max) Change
-22.43%

Contact Information

https://www.medexus.com
877 633 3987
35 Nixon Road, Bolton, ON, L7E 1K1

Company Facts

82 Employees
IPO DateNov 27, 2017
CountryCA
Actively Trading

Frequently Asked Questions